Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-26-014937
Filing Date
2026-05-05
Accepted
2026-05-05 17:03:50
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 clnn20260417_424b5.htm 424B5 519751
2 clenelogo11percent.jpg GRAPHIC 10252
3 pipelinejan2025_22pct.jpg GRAPHIC 109216
4 pipelinemay2026_24.jpg GRAPHIC 94009
  Complete submission text file 0001437749-26-014937.txt   815203
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-286058 | Film No.: 26944427
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)